Vireo Growth (VREOF) Interest Expenses (2020 - 2026)

Vireo Growth (VREOF) reported Interest Expenses of $258.9 million for Q1 2026, up 3306.8% on a YoY basis from $7.6 million in Q1 2025, and up 3328.67% sequentially from $7.6 million in Q4 2025.

Vireo Growth (VREOF) Interest Expenses (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Interest Expenses data on file, last reported at $258.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Interest Expenses rose 3306.8% year-over-year to $258.9 million; the trailing twelve-month figure through Mar 2026 stood at $258.9 million (up 436.56% YoY), and the FY2025 full-year result was $28.6 million, down 10.45% from the prior year.
  • Interest Expenses grew to $258.9 million in Q1 2026, from $7.6 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $283.0 million in Q2 2024 to a low of $6.8 million in Q4 2023.
  • A 5-year average of $74.7 million and a median of $16.2 million in 2022 frame the typical range for Interest Expenses.
  • Across the five-year window, Interest Expenses plunged 96.46% in 2022 and jumped 3511.12% in 2025, its largest moves.
  • Tracing VREOF's Interest Expenses over 5 years: stood at $7.1 million in 2022, then fell by 5.19% to $6.8 million in 2023, then surged by 293.1% to $26.5 million in 2024, then tumbled by 71.55% to $7.6 million in 2025, then surged by 3328.67% to $258.9 million in 2026.
  • Business Quant data shows VREOF's Interest Expenses at $258.9 million in Q1 2026, $7.6 million in Q4 2025, and $265.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 62.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 944.51 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.77 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 2.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.21 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 590.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 258.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 258.90 Mn
Mar 31, 2026 258.90 Mn
Dec 31, 2025 7.55 Mn
Dec 31, 2025 7.55 Mn
Sep 30, 2025 265.91 Mn
Sep 30, 2025 265.91 Mn
Jun 30, 2025 61.05 Mn
Jun 30, 2025 61.05 Mn
Mar 31, 2025 7.60 Mn
Mar 31, 2025 7.60 Mn
Dec 31, 2024 26.54 Mn
Dec 31, 2024 26.54 Mn
Sep 30, 2024 7.36 Mn
Sep 30, 2024 7.36 Mn
Jun 30, 2024 282.96 Mn
Jun 30, 2024 282.96 Mn
Mar 31, 2024 20.00 Mn
Mar 31, 2024 20.00 Mn
Dec 31, 2023 6.75 Mn
Dec 31, 2023 6.75 Mn